CanadaMAR-Amlodipine 5 mg tablets (MARCAN; DIN 02371715; lots 2472021, 2472021A) — white to off-white, flat eight-sided tablets with a centre line, “210” and “5” on one side — may contain tablet(s) of Midodrine 2.5 mg. The lots were recalled because they may contain Midodrine 2.5 mg tablets, which are white, round, marked “M2” on one side with a line on the other. Immediately check your medication bottle, return any unusual tablets to your pharmacy, do not take the round tablets, and contact your health care professional or the company with questions.
What's being recalled
Depth of recall: Retailers, Wholesalers, Health care establishments.
Companies: MARCAN PHARMACEUTICALS INC., 2 Gurdwara Rd., Suite 400, Ottawa, ON, K2E 1A2.
How to identify it
Brand: MARCAN; Product Name: MAR-AMLODIPINE; Market Authorization: DIN 02371715; Dosage Form: Tablet; Strength: 5 MG; Lot: 2472021, 2472021A
The hazard
Affected lots may contain tablet(s) of Midodrine 2.5mg tablets.
What to do
Immediately check your medication bottle to ensure it only contains MAR-Amlodipine 5 mg tablets.
MAR-Amlodipine 5 mg tablets are white to off-white, flat and eight-sided, with a line across the middle. One side has "210" and "5" printed on it, and the other side is blank.
Midodrine 2.5 mg tablets are white, round, and marked with 'M2' on one side and have a line down the middle on the other side.
If your bottle contains any unusual tablets or if you are unsure, return it to your pharmacy.
If you are unable to get a replacement immediately, continue taking your medication as directed but do not take the round tablets.
Contact your health care professional or call 911 if you are dizzy, have unusually high blood pressure or slow heartbeats.
Seek immediate medical attention if you have chest pain, a sudden headache, an inability to move or feel a part of your body, or impaired speech.
If you have questions about this recall, contact Marcan Pharmaceuticals Inc. by calling 1-855-627-2261 or by emailing info@marcanpharma.com.
Report any health product-related side effects or complaints to Health Canada.
Additional information for health professionals:
Health care professionals, such as pharmacists, should check packages and bottles labelled MAR-Amlodipine 5 mg (amlodipine besylate) before dispensing to make sure they do not contain midodrine 2.5 mg tablets. Report any unusual bottles or other issues to the company and Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)